ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
6
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,418
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
Author(s):
L. Bonanno
,
C. Costa
,
M Majem
,
A. Favaretto
,
M Rugge
,
R. Rosell
Publication date:
2013-03-31
Journal:
Annals of Oncology
Keywords:
BRCA1 Protein
,
genetics
,
Carcinoma, Non-Small-Cell Lung
,
drug therapy
,
pathology
,
Carrier Proteins
,
Clinical Trials as Topic
,
Disease-Free Survival
,
Drug Therapy
,
Gene Expression Regulation, Neoplastic
,
drug effects
,
Humans
,
Kaplan-Meier Estimate
,
Lung Neoplasms
,
Nuclear Proteins
,
Platinum
,
administration & dosage
,
RNA, Messenger
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via crossref license)
Powered by
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ChemSpider related publications
Author and article information
Journal
PubMed ID::
23429864
DOI::
10.1093/annonc/mdt063
ScienceOpen disciplines:
Chemistry
Keywords:
BRCA1 Protein
,
genetics
,
Carcinoma, Non-Small-Cell Lung
,
drug therapy
,
pathology
,
Carrier Proteins
,
Clinical Trials as Topic
,
Disease-Free Survival
,
Drug Therapy
,
Gene Expression Regulation, Neoplastic
,
drug effects
,
Humans
,
Kaplan-Meier Estimate
,
Lung Neoplasms
,
Nuclear Proteins
,
Platinum
,
administration & dosage
,
RNA, Messenger
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
BRCA1 Protein
,
genetics
,
Carcinoma, Non-Small-Cell Lung
,
drug therapy
,
pathology
,
Carrier Proteins
,
Clinical Trials as Topic
,
Disease-Free Survival
,
Drug Therapy
,
Gene Expression Regulation, Neoplastic
,
drug effects
,
Humans
,
Kaplan-Meier Estimate
,
Lung Neoplasms
,
Nuclear Proteins
,
Platinum
,
administration & dosage
,
RNA, Messenger
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,418
RAP80 suppresses the vulnerability of R-loops during DNA double-strand break repair
Authors:
Takaaki Yasuhara
,
Reona Kato
,
Motohiro Yamauchi
…
The de-ubiquitylating enzymes USP26 and USP37 regulate homologous recombination by counteracting RAP80
Authors:
Dimitris Typas
,
Martijn S. Luijsterburg
,
Wouter W. Wiegant
…
Impaired TIP60-mediated H4K16 acetylation accounts for the aberrant chromatin accumulation of 53BP1 and RAP80 in Fanconi anemia pathway-deficient cells
Authors:
E Renaud
,
A Barascu
,
F Rosselli
See all similar
Cited by
6
Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
Authors:
Xiaobing Qin
,
Shaorong Yu
,
Leilei Zhou
…
Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes
Authors:
Xiaobing Qin
,
Shaorong Yu
,
Xiaoyue Xu
…
Associations of Polymorphisms in DNA Repair Genes and MDR1 Gene with Chemotherapy Response and Survival of Non-Small Cell Lung Cancer
Authors:
Yan Du
,
Tong Su
,
Lijun Zhao
…
See all cited by
Version 1
Version 1